http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_722eb783c7b2ff58d5cbc9378ff13e23
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Edelman |
| name | Martin J Edelman Martin J. Edelman |
| given-name | Martin J. Martin J |
| organization-name | From the University of Chicago, Chicago; Ingalls Hospital, Harvey, IL, and the University of Maryland, Baltimore, MD. From the Wake Forest University School of Medicine, Winston-Salem; Department of Biostatistics and Bioinformatics, and Cancer and Leukemia Group B Statistical Center, Duke University Medical Center, Durham; University of North Carolina, Chapel Hill, NC; University of Iowa College of Pharmacy; University of Iowa Hospitals, Iowa City, IA; Memorial Sloan-Kettering Cancer Center, New York; Roswell Park Cancer Institute, Buffalo, NY; University of Chicago Medical Center, Chicago, IL; Georgetown University... Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111, USA Fox Chase Cancer Center, Philadelphia, PA, USA. Electronic address: martin.edelman@fccc.edu. University of Maryland Greenebaum Cancer Center, Baltimore, MD 21201, USA. medelman@umm.edu Fox Chase Cancer Center, Philadelphia, PA Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania; 1Greenebaum Cancer Center and Martin J. Edelman, Josephine Feliciano, Yang Yang, and Michelle Medeiros, University of Maryland Greenebaum Cancer Center, Baltimore, MD; Ming T. Tan, Georgetown University, Washington, DC; Mary J. Fidler, Rush University Medical Center, Chicago, IL; Rachel E. Sanborn, Providence Portland Medical Center, Portland, OR; Greg Otterson, The Ohio State University Comprehensive Cancer Center, Columbus, OH; Lecia V. Sequist, Massachusetts General Hospital Cancer Center, Boston, MA; Tracey L. Evans, University... 1University of Maryland Greenebaum Cancer Center, Baltimore, Maryland; Department of Hematology and Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania From the Stanford Cancer Institute, Stanford University, Stanford, CA; University of California, Davis Cancer Center, Sacramento, CA; University of New Mexico Cancer Center, Albuquerque, NM. From the School of Pharmacy, University of Maryland; University of Maryland Greenebaum Cancer Center, Baltimore, MD; and sanofi-aventis, Bridgewater, NJ. From the University of Maryland Greenebaum Cancer Center, Baltimore, MD; Southwest Oncology Group Statistical Center and Puget Sound Oncology Consortium, Seattle, WA; University of Colorado Health Sciences Center, Denver, CO; University of California Davis Cancer Center, Sacramento, CA; University of Texas Health Science Center, San Antonio, TX; and University of Kansas Medical Center, Kansas City, MO. Authors' Affiliations: 1Department of Oncology and Diagnostic Sciences, University of Maryland School of Dentistry; 2Marlene and Stewart Greenebaum Cancer Center, University of Maryland, Baltimore, Maryland; 3Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Thoracic Medical Oncology, Peking University Cancer Hospital & Institute, Beijing; and 4Department of Thoracic Surgery, Affiliated Tumor Hospital of Guangxi University, Nanning, Guangxi, China From the University of Maryland Greenebaum Cancer Center, Baltimore, MD; Duke University, Durham, NC; CALGB Pathology Central Office, Ohio State University, Columbus, OH; University of Minnesota, Minneapolis, MN; University of Chicago, Chicago, IL; Upstate Medical University and VA Medical Center, Syracuse, NY; Christiana Hospital, Wilmington, DE; and the Medical University of South Carolina, Charleston, SC Fox Chase Comprehensive Cancer Center, Philadelphia, Pennsylvania From the Wake Forest University School of Medicine, Winston-Salem, NC; University of Iowa College of Pharmacy; University of Iowa Hospitals, Iowa City, IA; Department of Biostatistics and Bioinformatics and Cancer and Leukemia Group B Statistical Center, Duke University Medical Center, Durham, NC; Dartmouth Medical School, Lebanon, NH; Cancer and Leukemia Group B; University of Chicago Medical Center, Chicago, IL; Georgetown University Medical Center, Washington, DC; Ohio State University Medical Center,... Patricia M. LoRusso, Karen M. Forman, MaryJo Pilat, Jing Li, Elisabeth I. Heath, and Lisa M. Malburg, Karmanos Cancer Institute, Wayne State University, Detroit, MI; Martin J. Edelman, Mary F. Quinn, and Edward A. Sausville, Marlene and Stewart Greenebaum Cancer Center, University of Maryland, Baltimore, MD; and Susan L. Bever, Patrick J. Klein, Christopher P. Leamon, and Richard A. Messmann, Endocyte, West Lafayette, IN. University of Maryland, Division of Hematology/Oncology, Greenebaum Cancer Center, Baltimore, 21201, USA. medelman@umm.edu David R. Spigel, Sarah Cannon Research Institute, Nashville, TN; Martin J. Edelman, University of Maryland Greenebaum Cancer Center, Baltimore, MD; Kenneth O’Byrne, Queensland University of Technology, Brisbane, Queensland, Australia; Luis Paz-Ares, Hospital Universitario Doce de Octubre and Centro Nacional de Investigaciones Oncológicas, Madrid; University of Seville, Seville, Spain; Simonetta Mocci, See Phan, David S. Shames, Dustin Smith, Wei Yu, and Virginia E. Paton, Genentech, South San Francisco,... Pasi A. Jänne and Marzia Capelletti, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, MA; Xiaofei Wang, Jeffrey Crawford, and Lin Gu, Duke University Medical Center, Durham; Mark A. Socinski and Thomas E. Stinchcombe, University of North Carolina, Chapel Hill, NC; Martin J. Edelman, University of Maryland, Baltimore, MD; Miguel A. Villalona-Calero, The Ohio State University, Columbus, OH; Robert Kratzke, University of Minnesota, Minneapolis, MN; Everett E. Vokes, University of... University of Maryland Greenebaum Cancer Center, Baltimore, MD University of Maryland Greenebaum Cancer Center, 22 S. Greene Street, Baltimore, MD 21201, USA ; ; Glenwood D. Goss and Ian Lorimer, Ottawa Hospital Cancer Center, University of Ottawa, Ottawa; Chris O'Callaghan and Keyue Ding, NCIC CTG, Queens University, Kingston; Ming-Sound Tsao and Frances A. Shepherd, University Health Network, Princess Margaret Hospital, University of Toronto, Toronto; Jonathan Noble, Northeast Cancer Center, Sudbury, Ontario; Charles Butts, Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada; Gregory A. Masters, Christiana Care's Helen F. Graham Cancer... University of Maryland Greenebaum Cancer Center, Baltimore, Maryland 21201-1595, USA, medelman@umm.edu Department of Medical Oncology, Fox Chase Comprehensive Cancer Center, Philadelphia, Pennsylvania. University of Maryland Greenebaum Cancer Center, Baltimore, MD 21201, USA ; Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, PA From the University of Maryland Marlene and Stewart Greenebaum Cancer Center, Baltimore, MD From the Department of Neurology (Drs. Khosla and Reich) and Greenebaum Cancer Center (Dr. Edelman and N. Kennedy), The University of Maryland School of Medicine, Baltimore, MD. Fox Chase Cancer Center, Philadelphia, Pennsylvania (A.K., D.S.W., M.J.E., E.M.H., R.G.U., R.I.F.) Jason K. Molitoris, University of Maryland Medical Center, Baltimore, MD; Martin J. Edelman, University of Maryland Greenebaum Cancer Center, Baltimore, MD; and William F. Regine and Steven J. Feigenberg, University of Maryland School of Medicine, Baltimore, MD Division of Medical Oncology, Department of Medicine, University of Maryland Medical Center, Baltimore, Md. 5Fox Chase Cancer Center, Philadelphia, Pennsylvania. Division of Hematology/Oncology, University of Maryland Greenebaum Cancer Center, Baltimore, MD 21201-1595, USA. University of Maryland, Greenebaum Cancer Center, Baltimore, Maryland, USA Translational Core Laboratory, University of Maryland Marlene & Stewart Greenbaum Cancer Center, 22 South Greene Street, Baltimore, Maryland 21201, United States 1Program in Experimental Therapeutics, University of Maryland Marlene and Stewart Greenebaum Cancer Center, and Division of Hematology and Oncology, Department of Medicine, University of Maryland School of Medicine; Martin J. Edelman, University of Maryland Greenebaum Cancer Center, Baltimore, MD; Xiaofei Wang and Lydia Hodgson, Alliance Statistical and Data Center, Duke University; Thomas E. Stinchcombe, Duke University School of Medicine, Durham, NC; Richard T. Cheney, Roswell Park Cancer Institute, Buffalo; Ajeet Gajra, State University of New York Upstate Medical University, Syracuse, NY; Maria Q. Baggstrom, Washington University School of Medicine, St Louis, MO; Sachdev P. Thomas, Illinois Cancer Care, Peoria;... Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania Division of Hematology/Oncology, University of Maryland Greenebaum Cancer Center, Baltimore, MD 21126, USA. medelman@umm.edu 3Marlene and Stewart Greenebaum Cancer Center, University of Maryland School of Medicine, Baltimore, Maryland; University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, Maryland, USA University of Maryland Greenebaum Cancer Center, Baltimore, Maryland Martin J. Edelman, University of Maryland Greenebaum Cancer Center, Baltimore, MD; Claus-Peter Schneider, Zentralklinik Bad Berka, Bad Berka; Martin Reck, Hospital Grosshansdorf, Grosshansdorf, Germany; Chun-Ming Tsai, Taipei Veterans General Hospital, Taipei, Taiwan; Heung-Tae Kim, National Cancer Center, Goyang-Si, Korea; Elisabeth Quoix, Nouvel Hopital Civil, Strasbourg, France; Alexander V. Luft, Leningrad Regional Clinical Hospital, St Petersburg, Russia; and Remigiusz Kaleta, Pralay Mukhopadhyay,... Department of Hematology/Oncology, University of Maryland, Marlene and Stewart Greenebaum Cancer Center, Baltimore; now with Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania Department of Hematology/Oncology Fox Chase Cancer Center Philadelphia Pennsylvania |
Incoming Links
Total number of triples: 243.